Literature DB >> 27377598

Identification of a novel mutation of the PRKAR1A gene in a patient with Carney complex with significant osteoporosis and recurrent fractures.

Labrini Papanastasiou1, Stelios Fountoulakis1, Nikos Voulgaris1, Theodora Kounadi1, Theodosia Choreftaki2, Akrivi Kostopoulou2, George Zografos3, Charalampos Lyssikatos4, Constantine A Stratakis4, George Piaditis1.   

Abstract

OBJECTIVE: Carney complex (CNC) is a rare autosomal dominant multiple neoplasia syndrome characterized by the presence of endocrine and non-endocrine tumors. More than 125 different germline mutations of the protein Kinase A type 1-α regulatory subunit (PRKAR1A) gene have been reported. We present a novel PRKAR1A gene germline mutation in a patient with severe osteoporosis and recurrent vertebral fractures.
DESIGN: Clinical case report. CASE REPORT: A 53-year-old male with a medical history of surgically removed recurrent cardiac myxomas was evaluated for repeated low-pressure vertebral fractures and severe osteoporosis. Physical examination revealed spotty skin pigmentation of the lower extremities and papules in the nuchal and thoracic region. The presence of hypercortisolism due to micronodular adrenal disease and the history of cardiac myxomas suggested the diagnosis of CNC; the patient underwent detailed imaging investigation and genetic testing.
METHODS: Standard imaging and clinical testing; DNA was sequenced by the Sanger method.
RESULTS: Sequence analysis from peripheral lymphocytes DNA revealed a novel heterozygous point mutation at codon 172 of exon 2 (c.172G>T) of the PRKAR1A gene, resulting in early termination of the PRKAR1A transcript [p.Glu58Ter (E58X)].
CONCLUSION: We report a novel point mutation of the PRKAR1A gene in a patient with CNC who presented with significant osteoporosis and fractures. Low bone mineral density along with recurrent myxomas should point to the diagnosis of CNC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27377598      PMCID: PMC7427502          DOI: 10.14310/horm.2002.1627

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  25 in total

1.  Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing.

Authors:  Paraskevi Salpea; Anelia Horvath; Edra London; Fabio R Faucz; Annalisa Vetro; Isaac Levy; Evgenia Gourgari; Andrew Dauber; Ingrid A Holm; Patrick J Morrison; Margaret F Keil; Charalampos Lyssikatos; Eric D Smith; Marc A Sanidad; JoAnn C Kelly; Zunyan Dai; Philip Mowrey; Antonella Forlino; Orsetta Zuffardi; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  PRKAR1A in the development of cardiac myxoma: a study of 110 cases including isolated and syndromic tumors.

Authors:  Joseph J Maleszewski; Brandon T Larsen; Nefize Sertac Kip; Mathieu C Castonguay; William D Edwards; J Aidan Carney; Benjamin R Kipp
Journal:  Am J Surg Pathol       Date:  2014-08       Impact factor: 6.394

3.  Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6.

Authors:  Sylvie Huybers; Ton H J Naber; René J M Bindels; Joost G J Hoenderop
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08-10       Impact factor: 4.052

4.  Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease.

Authors:  C A Stratakis; N Sarlis; L S Kirschner; J A Carney; J L Doppman; L K Nieman; G P Chrousos; D A Papanicolaou
Journal:  Ann Intern Med       Date:  1999-10-19       Impact factor: 25.391

5.  Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.

Authors:  Jérôme Bertherat; Anélia Horvath; Lionel Groussin; Sophie Grabar; Sosipatros Boikos; Laure Cazabat; Rosella Libe; Fernande René-Corail; Sotirios Stergiopoulos; Isabelle Bourdeau; Thalia Bei; Eric Clauser; Alain Calender; Lawrence S Kirschner; Xavier Bertagna; J Aidan Carney; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

6.  Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.

Authors:  Felix Beuschlein; Martin Fassnacht; Guillaume Assié; Davide Calebiro; Constantine A Stratakis; Andrea Osswald; Cristina L Ronchi; Thomas Wieland; Silviu Sbiera; Fabio R Faucz; Katrin Schaak; Anett Schmittfull; Thomas Schwarzmayr; Olivia Barreau; Delphine Vezzosi; Marthe Rizk-Rabin; Ulrike Zabel; Eva Szarek; Paraskevi Salpea; Antonella Forlino; Annalisa Vetro; Orsetta Zuffardi; Caroline Kisker; Susanne Diener; Thomas Meitinger; Martin J Lohse; Martin Reincke; Jérome Bertherat; Tim M Strom; Bruno Allolio
Journal:  N Engl J Med       Date:  2014-02-26       Impact factor: 91.245

7.  Identification of a novel genetic locus for familial cardiac myxomas and Carney complex.

Authors:  M Casey; C Mah; A D Merliss; L S Kirschner; S E Taymans; A E Denio; B Korf; A D Irvine; A Hughes; J A Carney; C A Stratakis; C T Basson
Journal:  Circulation       Date:  1998-12-08       Impact factor: 29.690

8.  Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2.

Authors:  C A Stratakis; J A Carney; J P Lin; D A Papanicolaou; M Karl; D L Kastner; E Pras; G P Chrousos
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.

Authors:  Alberto M Pereira; Frederik J Hes; Anelia Horvath; Sanne Woortman; Elizabeth Greene; Eirini Bimpaki; Anton Alatsatianos; Sosipatros Boikos; Johannes W Smit; Johannes A Romijn; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-11-13       Impact factor: 5.958

10.  Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.

Authors:  Lionel Groussin; Eric Jullian; Karine Perlemoine; Albert Louvel; Bruno Leheup; Jean Pierre Luton; Xavier Bertagna; Jérôme Bertherat
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

View more
  2 in total

1.  Association between subclinical hyperthyroidism and a PRKAR1A gene variant in Carney complex patients: A case report and systematic review.

Authors:  Hongyang Wang; Min Mao; Dongfang Liu; Lian Duan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

Review 2.  Carney complex with PRKAR1A gene mutation: A case report and literature review.

Authors:  Qiuli Liu; Dali Tong; Gaolei Liu; Yuting Yi; Dianzheng Zhang; Jun Zhang; Yao Zhang; Zaoming Huang; Yaoming Li; Rongrong Chen; Yanfang Guan; Xin Yi; Jun Jiang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.